Plain-English translation of NCT04904757 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing contrast-enhanced spectral mammography (CESM), a newer breast imaging tool that uses a special dye to help detect breast cancer in women who have dense breast tissue. Researchers want to understand whether women are comfortable having this scan as part of their regular breast cancer screening, and what their experience is like before and after the procedure.
While CESM has been approved by the FDA and can be very helpful for finding breast cancer—especially in women with dense breast tissue—many doctors and patients haven't started using it yet. This study aims to understand what concerns women have and what would help more people feel confident choosing this screening option.
You likely qualify if…
You likely don't qualify if…
You would complete a short survey before having the CESM scan, answering questions about your thoughts on breast cancer risk and any concerns you have about the imaging procedure. Then you would receive the contrast-enhanced mammography scan, which is performed at a medical center. After the scan, you would complete another brief survey sharing how you felt about the experience. The scan counts as your annual screening mammogram for your regular care.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States
Sponsor
University of Virginia
Enrollment target
~210 participants
Started
September 2019
Primary completion
December 2022
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years – 69 Years
Sex
Female only
Last updated on clinicaltrials.gov in November 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kathy L Repich, RN
University of Virginia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.